- Home
- MSCI vs TAK Comparison
MSCI vs TAK Comparison
Compare MSCI & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSCI
- TAK
- Stock Information
- Founded
- MSCI 1998
- TAK 1781
- Country
- MSCI United States
- TAK Japan
- Employees
- MSCI N/A
- TAK N/A
- Industry
- MSCI Business Services
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- MSCI Consumer Discretionary
- TAK Health Care
- Exchange
- MSCI Nasdaq
- TAK Nasdaq
- Market Cap
- MSCI 44.5B
- TAK 47.0B
- IPO Year
- MSCI 2007
- TAK N/A
- Fundamental
- Price
- MSCI $556.59
- TAK $14.37
- Analyst Decision
- MSCI Buy
- TAK
- Analyst Count
- MSCI 12
- TAK 0
- Target Price
- MSCI $645.36
- TAK N/A
- AVG Volume (30 Days)
- MSCI 506.1K
- TAK 2.0M
- Earning Date
- MSCI 04-22-2025
- TAK 05-08-2025
- Dividend Yield
- MSCI 1.29%
- TAK 4.08%
- EPS Growth
- MSCI N/A
- TAK N/A
- EPS
- MSCI 14.54
- TAK 0.45
- Revenue
- MSCI $2,921,989,000.00
- TAK $30,595,075,281.00
- Revenue This Year
- MSCI $9.94
- TAK $0.87
- Revenue Next Year
- MSCI $8.28
- TAK $1.69
- P/E Ratio
- MSCI $38.27
- TAK $63.69
- Revenue Growth
- MSCI 11.67
- TAK 7.45
- 52 Week Low
- MSCI $472.38
- TAK $12.58
- 52 Week High
- MSCI $642.45
- TAK $15.37
- Technical
- Relative Strength Index (RSI)
- MSCI 54.81
- TAK 40.48
- Support Level
- MSCI $542.39
- TAK $14.22
- Resistance Level
- MSCI $563.17
- TAK $15.43
- Average True Range (ATR)
- MSCI 12.18
- TAK 0.20
- MACD
- MSCI 2.89
- TAK -0.08
- Stochastic Oscillator
- MSCI 85.96
- TAK 11.98
About MSCI MSCI Inc.
MSCI has described its mission as enabling investors to build better portfolios for a better world. MSCI's largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. In addition, it boasts over $1.7 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. MSCI's all other segment was broken out into ESG and climate and private assets segments in 2021. In ESG and climate, MSCI provides ESG data to the investment industry. In private assets, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.